Prostate Cancer
Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level - Abstract
November 13, 2012
Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer - Abstract
November 13, 2012
Impact of late anorectal dysfunction on quality of life after pelvic radiotherapy - Abstract
November 13, 2012
Imaging of bone metastases in prostate cancer: An update - Abstract
November 13, 2012
Metabolic syndrome and androgen deprivation therapy in metabolic complications of prostate cancer patients - Abstract
November 13, 2012
Investigation of optimal prostate biopsy schemes for Chinese patients with different clinical characteristics - Abstract
November 13, 2012
Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy? - Abstract
November 12, 2012
Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients - Abstract
November 12, 2012
Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer - Abstract
November 10, 2012
Landmarks in hormonal therapy for prostate cancer - Abstract
November 10, 2012
Lymph nodal metastases: Diagnosis and treatment - Abstract
November 10, 2012
Advances in oncologic imaging: Update on 5 common cancers - Abstract
November 10, 2012
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese - Abstract
November 10, 2012
Optimal prostate biopsy regimen - Abstract
November 10, 2012